Najah Doka, MD, MPH, at ID Care
Najah Doka, Infectious Disease Doctor
Infectious disease physician expertise
- Board certified in infectious disease by the American Board of Internal Medicine (ABIM)
- Specializing in the treatment of all infectious diseases
Education
- Infectious Disease Fellowship: University of Virginia (2011)
- Graduate: Master in Public Health at the University of Virginia (2009)
- Internal Medicine Residency: Duke University (2008)
- Medical School: New York University (2005)
- Undergraduate: Pennsylvania State University (2001)
Hospital Affiliations
- Morristown Medical Center, Morristown, NJ
- Newton Medical Center, Newton, NJ
- Overlook Medical Center, Summit, NJ
Why I’m an infectious disease specialist
“The HIV epidemic piqued my interest in infectious diseases. But more importantly the devastation of infection from malaria, poor sanitation and diarrheal illness – and how quickly recovery from these illnesses would be with the right medications – inspired me to become a doctor. Being an infectious disease doctor meant I could cure an illness and make an immediate difference in a patient’s life. HIV went from a death sentence to now patients living happily and raising families for decades.”
Approach to infectious disease care
Dr. Najah Doka believes that listening to the patient and taking a thorough history directly from the patient or their family is invaluable. As a consultant, she recognizes that the story of the patient she sees may have evolved or changed after being seen by other physicians. By hearing directly from patients, carefully examining them and allowing adequate time for this process, Dr. Doka creates a safe environment where patients feel comfortable sharing critical information. This approach ensures valuable insights that aid in delivering the best possible care.
More about Najah Doka, infectious disease doctor
Growing up during the HIV epidemic, Dr. Najah Doka witnessed firsthand the devastating impact of infectious diseases and felt compelled to make a difference. Her passion for medicine stems from the ability to help people live longer, healthier lives by providing simple yet life-changing treatments such as vaccines or medications. As an infectious disease specialist, Dr. Doka finds immense satisfaction in seeing a patient recover fully from an infection, particularly when she can work alongside other physicians to diagnose and treat complex cases.
Dr. Doka says her humor is one of her greatest assets. She strives to lighten the mood when appropriate, helping patients understand that she empathizes with them. She also builds confidence by grounding her treatment plans in concrete data and the latest clinical guidelines as the basis for therapy. Dr. Doka spends as much time with patients as needed to answer all their questions and to explain the treatment in as much detail that is understandable by the individual.
Outside of her medical practice, Dr. Doka remains deeply connected to her roots in Africa where she is from and grew up. She actively participates in uplifting the community that inspired her journey into medicine. Through Tender Grassroots, a non-governmental organization in Uganda that not only helps reduce poverty and increases educational opportunities but increases health opportunities, she helps with the healthcare center by providing free and subsidized services, immunizations, health fairs and mother-child care clinics. Witnessing the transformation of a humble clinic under a tree into a fully functioning healthcare center brings her the most joy.
Leadership, Memberships & Research
Leadership
- In charge of infection control at one of the ID Care subacute facilities
Memberships
- American College of Physicians
- American Medical Association
- Infectious Diseases Society of America
Research
- Doka, Najah: The use of Popular Theatre as an HIV/AIDS Education Tool in Selected Sub-Saharan African Countries. Honors Thesis at University of Pennsylvania: 2001
- Xiang SH, Doka N, Choudhary RK, Sodroski J, Robinson JE: Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies. AIDS Research & Human Retroviruses. 18(16): 1207-17, 2002 Nov 1.
- Doka NI, Jacob ST, Banura P, Moore CC, Meya D, Mayanja-Kizza H, Reynolds SJ, Scheld WM, Yuan W. Enrichment of HIV-1 subtype AD recombinants in a Ugandan cohort of severely septic patients. PLoS One. 2012;7(10)
Awards & Honors
Life-changing results speak for themselves
“I have been truly impressed with the staff and their kindness and competence. I am thrilled!”